Centessa Pharmaceuticals · 2 days ago
(Sr.) Manager, Clinical Supply Chain
Boston, MA
Full-time
Hybrid
Senior Level
$145K/yr - $190K/yr
5+ years expCentessa Pharmaceuticals is a new kind of pharmaceutical company that prioritizes data-driven decision making in a deconstructed R&D environment. They are seeking a (Sr.) Manager, Clinical Supply Chain to oversee end-to-end planning and execution of clinical supply while ensuring compliance with GxP requirements and collaborating with various internal and external teams.
BiotechnologyPharmaceutical
Responsibilities
Lead development and execution of clinical supply strategies for early- to mid-phase clinical trials (Phase 1–3 as applicable)
Own clinical supply plans, demand forecasts, and inventory strategies aligned with protocol requirements and enrollment projections
Manage packaging, labeling, distribution, and resupply activities for investigational products and comparators
Ensure on-time delivery of clinical supplies to depots and clinical sites globally
Collaborate with Quality, Clinical, CMC and external CDMOs to develop and approve clinical labels
Manage CDMO packaging/labeling schedules to ensure availability of clinical supplies
Interact regularly with third-party providers to manage logistics & licenses required to ship materials from manufacturing to bulk storage facilities, courier depots and investigator sites
Work with CMC and QA to facilitate document transfer required for CTM/QP release by CDMOs
Manage and track clinical supply inventory either manually or through an Interactive Response Technology (IRT) system
Manage Product Recovery pending investigation of CTM from investigator sites as needed
Effectively collaborate and communicate across multiple functional areas, bringing a sufficient breadth of knowledge
Monitor shelf-life and expiry dating and coordinate retest extension with analytical team to ensure continuous supply
Manage investigation, reporting and communication of outcomes from temperature excursions and product complaints
Author Pharmacy Manuals for clinical studies, as needed
Represent Supply Chain in Clinical and CMC Sub Team meetings
Qualification
Required
Bachelor's degree in engineering or science is required
5-8 years of biotech/pharma industry experience in clinical supply with international experience is required
Experience in all aspects of clinical supply chain as well as a deep understanding of GMP/GDP
Requires a strong understanding of managing groups, CMOs and CDMOs
Proven background in working with small molecule modality required
Strong organizational, analytical, decision-making and interpersonal skills
Ability to work independently in a fast-paced dynamic environment
Demonstrated ability to coordinate CDMO activities in the development and commercialization of pharmaceutical products
Excellent organizational skills, project management skills and detail-orientated leadership approach
Ability to thrive in a small company culture and assist in creating and implementing processes
Preferred
Experience with blistering and walleting packaging processes preferred
Experience operating within a commercial drug product environment preferred
Benefits
Discretionary annual bonus
Participation in our equity program
401(k) plan
Company-sponsored medical, dental, vision, and life insurance
Generous paid time off
Health and wellness program
Company
Centessa Pharmaceuticals
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
51-200 employees
H1B Sponsorship
Centessa Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.12BKey Investors
Oberland Capital
2025-11-11Post Ipo Equity· $250M
2024-09-11Post Ipo Equity· $225M
2024-04-23Post Ipo Equity· $100M
Leadership Team
John Crowley
Chief Financial Officer
Gregory Weinhoff
Chief Business Officer
Recent News
2026-01-05
2025-12-14
Company data provided by crunchbase